- Report
- October 2024
- 194 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- September 2024
- 323 Pages
Global
From €3323EUR$3,500USD£2,803GBP
€4747EUR$5,000USD£4,004GBP
- Report
- March 2025
- 89 Pages
Global
From €5316EUR$5,600USD£4,484GBP
- Report
- February 2025
- 386 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- October 2024
- 187 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- December 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- March 2025
- 89 Pages
Global
From €5316EUR$5,600USD£4,484GBP
- Report
- July 2024
- 100 Pages
Global
From €3560EUR$3,750USD£3,003GBP
- Report
- July 2024
- 186 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- March 2023
- 420 Pages
Global
From €4556EUR$4,799USD£3,843GBP
- Report
- April 2022
- 334 Pages
Global
From €4556EUR$4,799USD£3,843GBP
- Report
- June 2018
- 315 Pages
Global
From €3322EUR$3,499USD£2,802GBP
- Report
- February 2020
- 240 Pages
Global
From €4651EUR$4,899USD£3,923GBP
- Report
- July 2022
- 689 Pages
Global
From €4847EUR$5,284USD£3,950GBP
- Report
- February 2023
- 178 Pages
Global
From €5600EUR$5,899USD£4,724GBP
- Report
- June 2020
- 294 Pages
Global
From €7832EUR$8,250USD£6,606GBP
- Report
- March 2023
- 334 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- August 2023
- 237 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- May 2023
- 150 Pages
Global
From €4604EUR$4,850USD£3,884GBP

The Drug Discovery Services market is a subset of the pharmaceutical industry that focuses on the development of new drugs. It involves the identification of potential drug targets, the design and synthesis of drug candidates, and the testing of these candidates for efficacy and safety. Drug discovery services are typically provided by contract research organizations (CROs) and include a range of services such as target identification, lead optimization, preclinical and clinical development, and regulatory support.
The Drug Discovery Services market is driven by the need for new and improved treatments for a variety of diseases, as well as the increasing demand for personalized medicines. The market is also driven by advances in technology, such as artificial intelligence and machine learning, which have enabled the development of more efficient and cost-effective drug discovery processes.
Some of the major companies in the Drug Discovery Services market include Charles River Laboratories, PPD, Inc., WuXi AppTec, Evotec, and Syngene International. Show Less Read more